We are Sorry, This Page doesn't Exist

Thomson Reuters A drug derived from marijuana to treat epilepsy is on the brink of becoming the first of its kind to win US government approval. The drug, called Epidiolex, contains a compound in cann.....»»

Shutterstock The Food and Drug Administration approved the first cannabis-derived drug on Wednesday. Called Epidiolex, the GW Pharmaceuticals drug is designed to treat two rare forms of childhood epilepsy using a m.....»»

If the Food and Drug Administration follows the group’s re.....»»

An FDA advisory panel recommended approval of what could become the first prescription drug in the U.S. derived from the marijuana plant, as a treatment for people with rare forms of epilepsy......»»

GW Pharmaceuticals on Monday received approval from the U.S. FDA for its epilepsy drug derived from the marijuana plant. This is the first drug of its kind to receive FDA approval......»»

Shutterstock The nation's top drug regulator has officially changed how.....»»

GW Pharma develops therapies derived from the marijuana plant, and was the first company to receive FDA approval for a cannabinoid-based therapy. Canada-based marijuana producer Aurora Cannabis pulled off a high sales volum.....»»

GW Pharmaceuticals Inc. reported revenue that topped the consensus estimates Tuesday, as the company’s marijuana-derived epilepsy drug continue to grow......»»

AP Photo/Gary Landers Police in El Paso, Texas, say they found 157 pounds of marijuana in a.....»»

Convicted “” Martin Shkreli was sued by federal officials and the state of New York for allegedly when he jacked up the price of a crucial drug by 4,000% overnight in 2015. The lawsuit was filed... To view the full story, click the title link......»»

WASHINGTON – A House committee gave preliminary approval Wednesday to a comprehensive marijuana reform bill that would decriminalize the drug while erasing pot convictions stretching back decades. The vote by the House Judiciary Committee came th.....»»

Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug Otezla, the Federal Trade Commission said in a statement on Friday......»»

Shares of GW Pharmaceuticals PLC sunk more than 12% in the extended session Tuesday, after the cannabinoid drug maker reported better-than-expected revenue from its flagship product, Epidiolex......»»

Federal drug enforcement officials want to boost the amount of marijuana that can be legally produced for research in the United States while cutting the number of opioids that can be manufactured in the country. read more.....»»

The Drug Enforcement Administration is moving forward with a program that would give federal clearance to new cannabis cultivators to grow marijuana for scientific research. read more.....»»

GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading......»»

GW Pharmaceuticals PLC shares rose more than 10% in the extended session Tuesday, after the company reported better-than-expected sales from its cannabis-derived epilepsy treatment drug......»»

A federal judge blocked a new requirement for drugmakers to display the price of medications in television ads, saying the Department of Health and Human Services overstepped its authority and would need approval from Congress......»»

Following the legalization of hemp-derived CBD on a federal level in December, manufacturers of CBD-infused products will be closely watching the Food and Drug Administration's first public hearing on the regulation of CBD products. read more.....»»

Immigration authorities on Friday said that anyone with any involvement with marijuana, regardless of whether it's legal in the state where they live, can be denied citizenship because the drug is still illegal under federal law......»»